Menu
Recruiting NCT06947655

Impact of Different Perioperative Tourniquets on Blood Loss and Surgeon Satisfaction in Total Knee Arthroplasty

No phase Interventional Total Knee Arthroplasty

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: VBM Tourniquet, Adaptive Cuff.
Who it may be relevant to
Registry conditions: Total Knee Arthroplasty. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Impact of Two Different Perioperative Tourniquets on Blood Loss, Surgical Field and Surgeon Satisfaction During Total Knee Arthroplasty

Overview

The present study investigates the impact of two different perioperative tourniquets with different closing features on operative blood los, surgical field quality and surgeon satisfaction.

Interventions

  • Device VBM Tourniquet
    Perioperative VBM-Tourniquet Application with a fixation pressure of 15mmHg.
  • Device Adaptive Cuff
    Perioperative Delfi-Tourniquet Application with a fixation pressure of 15mmHg.

Primary outcome measures

  • Blood Loss [Time frame: Perioperative]
  • Surgeon Satisfaction [Time frame: Perioperative]

Eligibility criteria

Inclusion criteria

  • Inidication for a Total Knee Arthroplasty
  • Approval for Surgery by the Department of Anesthesia

Exclusion criteria

  • Open Wounds of the lower extremities
  • Acute or chronic infections of the lower extremities

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Other

Study locations

Germany · 1 center
  • University Hospital Bonn — Bonn

Identifiers

NCT: NCT06947655 · 2024_J

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗